Omar Alkharabsheh, MD, discusses remaining challenges in high-risk chronic lymphocytic leukemia.
Omar Alkharabsheh, MD
Advertisement
Articles by Omar Alkharabsheh, MD
Omar Alkharabsheh, MD, discusses ongoing research efforts examining combination therapies in patients with mantle cell lymphoma.
Omar Alkharabsheh, MD, discusses emerging treatment options in chronic lymphocytic leukemia.
Omar Alkharabsheh, MD, discusses future research directions for the treatment of patients with myeloproliferative neoplasms.
Omar Alkharabsheh, MD, discusses novel agents under exploration in the field of myelofibrosis.
Omar Alkharabsheh, MD, discusses the current goals of treatment in myeloproliferative neoplasms.
Advertisement
Latest Updated Articles
Dr. Alkharabsheh on Ongoing Research Efforts Examining Novel Combos in MCLPublished: May 10th 2021 | Updated:
Dr. Alkharabsheh on Emerging Treatment Options in CLLPublished: May 5th 2021 | Updated:
Dr. Alkharabsheh on Future Research Directions in MPNsPublished: May 5th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5